{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:36:20Z","timestamp":1790231780951,"version":"4.1.0"},"reference-count":161,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.arr.2015.08.001","type":"journal-article","created":{"date-parts":[[2015,8,22]],"date-time":"2015-08-22T15:45:45Z","timestamp":1440258345000},"page":"178-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"special_numbering":"PB","title":["Estrogen receptor \u03b2 in Alzheimer\u2019s disease: From mechanisms to therapeutics"],"prefix":"10.1016","volume":"24","author":[{"given":"Liqin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah K.","family":"Woody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindit","family":"Chhibber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2015.08.001_bib0005","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1523\/JNEUROSCI.22-09-03608.2002","article-title":"Estrogen and aging affect the subcellular distribution of estrogen receptor-alpha in the hippocampus of female rats","volume":"22","author":"Adams","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2015.08.001_bib0010","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/j.1471-4159.2010.07038.x","article-title":"Progesterone inhibits estrogen-mediated neuroprotection against excitotoxicity by down-regulating estrogen receptor-beta","volume":"115","author":"Aguirre","year":"2010","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2015.08.001_bib0015","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1460-9568.2008.06591.x","article-title":"Progesterone reverses 17beta-estradiol-mediated neuroprotection and BDNF induction in cultured hippocampal slices","volume":"29","author":"Aguirre","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.arr.2015.08.001_bib0020","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/ana.24135","article-title":"Sex modifies the APOE-related risk of developing Alzheimer disease","volume":"75","author":"Altmann","year":"2014","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.arr.2015.08.001_bib0025","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1136\/jnnp.2007.136903","article-title":"Risk profiles for mild cognitive impairment and progression to dementia are gender specific","volume":"79","author":"Artero","year":"2008","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.arr.2015.08.001_bib0030","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1677\/erc.1.00800","article-title":"Loss of ERbeta expression as a common step in estrogen-dependent tumor progression","volume":"11","author":"Bardin","year":"2004","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.arr.2015.08.001_bib0035","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1001\/archpsyc.62.6.685","article-title":"Sex differences in the clinical manifestations of Alzheimer disease pathology","volume":"62","author":"Barnes","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.arr.2015.08.001_bib0040","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1016\/j.neurobiolaging.2011.01.001","article-title":"Structural brain changes in normal individuals with a maternal history of Alzheimer\u2019s","volume":"32","author":"Berti","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2015.08.001_bib0045","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/08977190410001723308","article-title":"Brain-derived neurotrophic factor","volume":"22","author":"Binder","year":"2004","journal-title":"Growth Factors"},{"key":"10.1016\/j.arr.2015.08.001_bib0050","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00002093-199910000-00007","article-title":"Evidence for an interaction between apolipoprotein E genotype, gender, and Alzheimer disease","volume":"13","author":"Bretsky","year":"1999","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.arr.2015.08.001_bib0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1196\/annals.1347.005","article-title":"Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action","volume":"1052","author":"Brinton","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.arr.2015.08.001_bib0060","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.tins.2008.07.003","article-title":"The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications","volume":"31","author":"Brinton","year":"2008","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.arr.2015.08.001_bib0065","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tips.2008.12.006","article-title":"Estrogen-induced plasticity from cells to circuits: predictions for cognitive function","volume":"30","author":"Brinton","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.arr.2015.08.001_bib0070","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jalz.2010.11.007","article-title":"National estimates of the prevalence of Alzheimer\u2019s disease in the United States","volume":"7","author":"Brookmeyer","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2015.08.001_bib0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3233\/JAD-2004-6302","article-title":"Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4","volume":"6","author":"Burkhardt","year":"2004","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"10.1016\/j.arr.2015.08.001_bib0080","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1089\/jwh.2012.3789","article-title":"Sex and gender differences in Alzheimer\u2019s disease: recommendations for future research","volume":"21","author":"Carter","year":"2012","journal-title":"J. Womens Health (Larchmt.)"},{"key":"10.1016\/j.arr.2015.08.001_bib0085","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jalz.2013.05.1763","article-title":"APOE interacts with age to modify rate of decline in cognitive and brain changes in Alzheimer\u2019s disease","volume":"10","author":"Chang","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2015.08.001_bib0090","first-page":"1","article-title":"Women have farther to fall: gender differences between normal elderly and Alzheimer\u2019s disease in verbal memory engender better detection of Alzheimer\u2019s disease in women","author":"Chapman","year":"2011","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.arr.2015.08.001_bib0095","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/nature13800","article-title":"A three-dimensional human neural cell culture model of Alzheimer\u2019s disease","volume":"515","author":"Choi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.arr.2015.08.001_bib0100","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3233\/JAD-122308","article-title":"Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer\u2019s disease","volume":"35","author":"Claxton","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2015.08.001_bib0105","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.arr.2015.08.001_bib0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbr.2005.05.011","article-title":"Beta estrogen receptor knockout (BERKO) mice present attenuated hippocampal CA1 long-term potentiation and related memory deficits in contextual fear conditioning","volume":"164","author":"Day","year":"2005","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.arr.2015.08.001_bib0115","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/gtmb.2008.0129","article-title":"Estrogen receptor beta gene variant is associated with vascular dementia in elderly women","volume":"13","author":"Dresner-Pollak","year":"2009","journal-title":"Genet. Test Mol. Biomark."},{"key":"10.1016\/j.arr.2015.08.001_bib0120","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1159\/000335541","article-title":"Progression from amnesic mild cognitive impairment to Alzheimer\u2019s disease: ESR1 and ESR2 polymorphisms and APOE gene","volume":"32","author":"Elcoroaristizabal Martin","year":"2011","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.arr.2015.08.001_bib0125","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1001\/jama.291.24.2959","article-title":"Conjugated equine estrogens and global cognitive function in postmenopausal women: Women\u2019s Health Initiative Memory Study","volume":"291","author":"Espeland","year":"2004","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.arr.2015.08.001_bib0130","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","article-title":"Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium","volume":"278","author":"Farrer","year":"1997","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.arr.2015.08.001_bib0135","doi-asserted-by":"crossref","first-page":"e003200","DOI":"10.1136\/bmjopen-2013-003200","article-title":"Oestrogen receptor polymorphisms are an associated risk factor for mild cognitive impairment and Alzheimer disease in women APOE {varepsilon}4 carriers: a case-control study","volume":"3","author":"Fernandez-Martinez","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.arr.2015.08.001_bib0140","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/sj.ejhg.5200714","article-title":"Investigations of a CA repeat in the oestrogen receptor beta gene in patients with Alzheimer\u2019s disease","volume":"9","author":"Forsell","year":"2001","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.arr.2015.08.001_bib0145","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.steroids.2008.04.006","article-title":"ERbeta in breast cancer-onlooker, passive player, or active protector?","volume":"73","author":"Fox","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.arr.2015.08.001_bib0150","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3389\/fphar.2014.00146","article-title":"Successful therapies for Alzheimer\u2019s disease: why so many in animal models and none in humans?","volume":"5","author":"Franco","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2015.08.001_bib0155","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.2174\/138161212800626139","article-title":"Estrogen receptor Beta in cancer: an attractive target for therapy","volume":"18","author":"Gallo","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.arr.2015.08.001_bib0160","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/373523a0","article-title":"Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein","volume":"373","author":"Games","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.arr.2015.08.001_bib0165","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archpsyc.55.9.809","article-title":"The relationship between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis","volume":"55","author":"Gao","year":"1998","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.arr.2015.08.001_bib0170","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1021\/cn400133s","article-title":"Nonsteroidal selective androgen receptor modulators and selective estrogen receptor beta agonists moderate cognitive deficits and amyloid-beta levels in a mouse model of Alzheimer\u2019s disease","volume":"4","author":"George","year":"2013","journal-title":"ACS Chem. Neurosc."},{"key":"10.1016\/j.arr.2015.08.001_bib0175","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3233\/JAD-2011-110362","article-title":"Study of estrogen receptor-alpha and receptor-beta gene polymorphisms on Alzheimer\u2019s disease","volume":"26","author":"Goumidi","year":"2011","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2015.08.001_bib0180","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/gme.0b013e31818e64dd","article-title":"MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial","volume":"16","author":"Grady","year":"2009","journal-title":"Menopause"},{"key":"10.1016\/j.arr.2015.08.001_bib0185","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/320134a0","article-title":"Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A","volume":"320","author":"Green","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.arr.2015.08.001_bib0190","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0165-6147(03)00229-3","article-title":"What pharmacologists can learn from recent advances in estrogen signaling","volume":"24","author":"Gustafsson","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.arr.2015.08.001_bib0195","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4236\/psych.2012.36068","article-title":"Bonston naming test: gender differences in older adults with and without Alzheimer\u2019s dementia","volume":"3","author":"Hall","year":"2012","journal-title":"Psychology"},{"key":"10.1016\/j.arr.2015.08.001_bib0200","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.steroids.2009.02.005","article-title":"Estrogen receptor beta in breast cancer-diagnostic and therapeutic implications","volume":"74","author":"Hartman","year":"2009","journal-title":"Steroids"},{"key":"10.1016\/j.arr.2015.08.001_bib0205","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.steroids.2012.07.002","article-title":"Current concepts and significance of estrogen receptor beta in prostate cancer","volume":"77","author":"Hartman","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/j.arr.2015.08.001_bib0210","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1210\/jc.2003-030862","article-title":"Changes in estrogen receptor-alpha and -beta in the infundibular nucleus of the human hypothalamus are related to the occurrence of Alzheimer\u2019s disease neuropathology","volume":"89","author":"Hestiantoro","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.arr.2015.08.001_bib0215","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1212\/WNL.0b013e31820e7b74","article-title":"Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease","volume":"76","author":"Honea","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2015.08.001_bib0220","doi-asserted-by":"crossref","first-page":"3228","DOI":"10.1073\/pnas.96.6.3228","article-title":"Plaque-independent disruption of neural circuits in Alzheimer\u2019s disease mouse models","volume":"96","author":"Hsia","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2015.08.001_bib0225","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.arr.2015.08.001_bib0230","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1080\/13803395.2012.712676","article-title":"Greater cognitive deterioration in women than men with Alzheimer\u2019s disease: a meta analysis","volume":"34","author":"Irvine","year":"2012","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.arr.2015.08.001_bib0235","doi-asserted-by":"crossref","DOI":"10.1080\/13803395.2012.712676","article-title":"Greater cognitive deterioration in women than men with Alzheimer\u2019s disease: a meta analysis","author":"Irvine","year":"2012","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.arr.2015.08.001_bib0240","doi-asserted-by":"crossref","first-page":"e54713","DOI":"10.1371\/journal.pone.0054713","article-title":"Accelerated cell aging in female APOE-epsilon4 carriers: implications for hormone therapy use","volume":"8","author":"Jacobs","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2015.08.001_bib0245","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.nlm.2010.08.016","article-title":"Estradiol and ERbeta agonists enhance recognition memory, and DPN, an ERbeta agonist, alters brain monoamines","volume":"94","author":"Jacome","year":"2010","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.arr.2015.08.001_bib0250","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3233\/JAD-130551","article-title":"Estrogen receptor beta variants modify risk for Alzheimer\u2019s disease in a multiethnic female cohort","volume":"40","author":"Janicki","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2015.08.001_bib0255","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0006-8993(98)00363-1","article-title":"Initiation and propagation stages of beta-amyloid are associated with distinctive apolipoprotein E, age, and gender profiles","volume":"798","author":"Johnson","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2015.08.001_bib0260","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1111\/j.1460-9568.2005.03953.x","article-title":"The effect of aging on the subcellular distribution of estrogen receptor-alpha in the cholinergic neurons of transgenic and wild-type mice","volume":"21","author":"Kalesnykas","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.arr.2015.08.001_bib0265","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.neurobiolaging.2010.10.007","article-title":"Postmenopausal hormone therapy, timing of initiation, APOE and cognitive decline","volume":"33","author":"Kang","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2015.08.001_bib0270","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jalz.2013.03.003","article-title":"Effect of APOE genotype status on targeted clinical trials outcomes and efficiency in dementia and mild cognitive impairment resulting from Alzheimer\u2019s disease","volume":"10","author":"Kennedy","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2015.08.001_bib0275","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer\u2019s disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2015.08.001_bib0280","doi-asserted-by":"crossref","first-page":"5925","DOI":"10.1073\/pnas.93.12.5925","article-title":"Cloning of a novel receptor expressed in rat prostate and ovary","volume":"93","author":"Kuiper","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2015.08.001_bib0285","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neulet.2013.12.032","article-title":"APOE modulates the effect of estrogen therapy on Abeta accumulation EFAD-Tg mice","volume":"560","author":"Kunzler","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2015.08.001_bib0290","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1136\/jmg.2003.005033","article-title":"The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer\u2019s disease","volume":"41","author":"Lambert","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.arr.2015.08.001_bib0295","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0304-3940(01)01806-7","article-title":"Are the estrogen receptors involved in Alzheimer\u2019s disease?","volume":"306","author":"Lambert","year":"2001","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2015.08.001_bib0300","doi-asserted-by":"crossref","first-page":"e319","DOI":"10.1016\/j.ddtec.2012.04.001","article-title":"Animal models of Alzheimer\u2019s disease and drug development","volume":"10","author":"Laurijssens","year":"2013","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.arr.2015.08.001_bib0305","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5607\/en.2013.22.2.84","article-title":"An update of animal models of Alzheimer disease with a reevaluation of plaque depositions","volume":"22","author":"Lee","year":"2013","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.arr.2015.08.001_bib0310","doi-asserted-by":"crossref","DOI":"10.1517\/13543784.2012.685652","article-title":"MF 101: a multi-component botanical selective estrogen receptor beta modulator for the treatment of menopausal vasomotor symptoms","author":"Leitman","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.arr.2015.08.001_bib0315","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1471-4159.2001.00627.x","article-title":"Brain region-specific up-regulation of mouse apolipoprotein E by pharmacological estrogen treatments","volume":"79","author":"Levin-Allerhand","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2015.08.001_bib0320","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2015.08.001_bib0325","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/nn2057","article-title":"Activation of estrogen receptor-beta regulates hippocampal synaptic plasticity and improves memory","volume":"11","author":"Liu","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.arr.2015.08.001_bib0330","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3233\/JAD-2012-120283","article-title":"New evidence of mitochondria dysfunction in the female Alzheimer\u2019s disease brain: deficiency of estrogen receptor-beta","volume":"30","author":"Long","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2015.08.001_bib0335","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1101\/lm.54603","article-title":"BDNF and activity-dependent synaptic modulation","volume":"10","author":"Lu","year":"2003","journal-title":"Learn. Mem."},{"key":"10.1016\/j.arr.2015.08.001_bib0340","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/01.wad.0000213861.12484.33","article-title":"Estrogen receptor beta gene (ESRbeta) 3\u2032-UTR variants in Alzheimer disease","volume":"20","author":"Luckhaus","year":"2006","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"10.1016\/j.arr.2015.08.001_bib0345","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/01.gme.0000191204.38664.61","article-title":"Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study","volume":"13","author":"MacLennan","year":"2006","journal-title":"Menopause"},{"key":"10.1016\/j.arr.2015.08.001_bib0350","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1056\/NEJMoa071513","article-title":"Estrogen therapy and coronary-artery calcification","volume":"356","author":"Manson","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2015.08.001_bib0355","unstructured":"McBride, R., September 14, 2012. Pharma counts just 3 Alzheimer\u2019s drug wins in 13 yeasr (101 losses). http:\/\/www.fiercebiotech.com\/story\/pharma-counts-just-3-alzheimers-drug-wins-13-years-101-losses\/2012-09-14."},{"key":"10.1016\/j.arr.2015.08.001_bib0360","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1210\/rp.57.1.357","article-title":"Estrogen actions throughout the brain","volume":"57","author":"McEwen","year":"2002","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.arr.2015.08.001_bib0365","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1073\/pnas.0905524107","article-title":"Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated","volume":"107","author":"McPherson","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2015.08.001_bib0370","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jalz.2011.02.011","article-title":"Effects of food and drug administration-approved medications for Alzheimer\u2019s disease on clinical progression","volume":"8","author":"Mielke","year":"2012","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2015.08.001_bib0375","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/1096-9861(20010115)429:3<355::AID-CNE1>3.0.CO;2-#","article-title":"Ultrastructural evidence that hippocampal alpha estrogen receptors are located at extranuclear sites","volume":"429","author":"Milner","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.arr.2015.08.001_bib0380","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1212\/WNL.57.1.89","article-title":"A gender difference in the association between APOE genotype and age-related cognitive decline","volume":"57","author":"Mortensen","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2015.08.001_bib0385","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1479-7364-4-3-170","article-title":"Maternal transmission of Alzheimer\u2019s disease: prodromal metabolic phenotype and the search for genes","volume":"4","author":"Mosconi","year":"2010","journal-title":"Hum. Genom."},{"key":"10.1016\/j.arr.2015.08.001_bib0390","first-page":"1778","article-title":"Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer\u2019s disease","volume":"47","author":"Mosconi","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2015.08.001_bib0395","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrd3842","article-title":"Sting of Alzheimer\u2019s failures offset by upcoming prevention trials","volume":"11","author":"Mullard","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2015.08.001_bib0400","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0301-0082(00)00014-9","article-title":"Brain-derived neurotrophic factor in the control human brain, and in Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"63","author":"Murer","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.arr.2015.08.001_bib0405","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1210\/en.2003-1707","article-title":"Estrogen facilitates neurite extension via apolipoprotein E in cultured adult mouse cortical neurons","volume":"145","author":"Nathan","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.arr.2015.08.001_bib0410","unstructured":"Neurology, A.A.O., 2007. Estrogen Use Before 65 Linked to Reduced Risk of Alzheimer\u2019s Disease. https:\/\/www.aan.com\/PressRoom\/Home\/PressRelease\/471."},{"key":"10.1016\/j.arr.2015.08.001_bib0415","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/1568007043337193","article-title":"Mitochondria as therapeutic targets of estrogen action in the central nervous system","volume":"3","author":"Nilsen","year":"2004","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.arr.2015.08.001_bib0420","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1358\/dnp.2005.18.9.948450","article-title":"Impact of clinically relevant progestins on the neural effects of estradiol and the signaling pathways involved","volume":"18","author":"Nilsen","year":"2005","journal-title":"Drug News Perspect."},{"key":"10.1016\/j.arr.2015.08.001_bib0425","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/nrd3551","article-title":"Development of subtype-selective oestrogen receptor-based therapeutics","volume":"10","author":"Nilsson","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.arr.2015.08.001_bib0430","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neulet.2003.10.064","article-title":"Subcellular localization of estrogen receptor beta in mouse hippocampus","volume":"355","author":"Nishio","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.arr.2015.08.001_bib0435","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer\u2019s disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.arr.2015.08.001_bib0440","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.arr.2015.08.001_bib0445","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1046\/j.1471-4159.2000.0751390.x","article-title":"The human brain has distinct regional expression patterns of estrogen receptor alpha mRNA isoforms derived from alternative promoters","volume":"75","author":"Osterlund","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.arr.2015.08.001_bib0450","first-page":"3840","article-title":"Estrogen receptor beta (ERbeta) messenger ribonucleic acid (mRNA) expression within the human forebrain: distinct distribution pattern to ERalpha mRNA","volume":"85","author":"Osterlund","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.arr.2015.08.001_bib0455","first-page":"803","article-title":"Gender difference in apolipoprotein E-associated risk for familial Alzheimer disease: a possible clue to the higher incidence of Alzheimer disease in women","volume":"58","author":"Payami","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.arr.2015.08.001_bib0460","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1158\/0008-5472.CAN-08-4523","article-title":"Estrogen receptor-beta affects the prognosis of human malignant mesothelioma","volume":"69","author":"Pinton","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.arr.2015.08.001_bib0465","doi-asserted-by":"crossref","first-page":"e14110","DOI":"10.1371\/journal.pone.0014110","article-title":"Estrogen receptor beta exerts tumor repressive functions in human malignant pleural mesothelioma via EGFR inactivation and affects response to gefitinib","volume":"5","author":"Pinton","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2015.08.001_bib0470","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.ejhg.5201447","article-title":"Estrogen receptor beta gene variants are associated with increased risk of Alzheimer\u2019s disease in women","volume":"13","author":"Pirskanen","year":"2005","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.arr.2015.08.001_bib0475","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0140-6736(93)91705-Q","article-title":"Apolipoprotein E polymorphism and Alzheimer\u2019s disease","volume":"342","author":"Poirier","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2015.08.001_bib0480","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.steroids.2007.10.013","article-title":"The role of estrogens and estrogen receptors in normal prostate growth and disease","volume":"73","author":"Prins","year":"2008","journal-title":"Steroids"},{"key":"10.1016\/j.arr.2015.08.001_bib0485","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1001\/jama.289.20.2663","article-title":"Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women\u2019s Health Initiative Memory Study: a randomized controlled trial","volume":"289","author":"Rapp","year":"2003","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.arr.2015.08.001_bib0490","first-page":"3","article-title":"Sex and gender differences in clinical medicine","author":"Regitz-Zagrosek","year":"2012","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.arr.2015.08.001_bib0495","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nlm.2005.10.003","article-title":"ERbeta-selective SERMs produce mnemonic-enhancing effects in the inhibitory avoidance and water maze tasks","volume":"85","author":"Rhodes","year":"2006","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.arr.2015.08.001_bib0500","unstructured":"Rice, S., January 25, 2014. As drug trials fail, Alzheimer\u2019s researchers look toward prevention. http:\/\/www.modernhealthcare.com\/article\/20140125\/MAGAZINE\/301259969#."},{"key":"10.1016\/j.arr.2015.08.001_bib0505","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1073\/pnas.012032699","article-title":"Disruption of estrogen receptor beta gene impairs spatial learning in female mice","volume":"99","author":"Rissman","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2015.08.001_bib0510","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.297.13.1465","article-title":"Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause","volume":"297","author":"Rossouw","year":"2007","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.arr.2015.08.001_bib0515","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.euroneuro.2013.06.003","article-title":"Prospective analysis of the association between estrogen receptor gene variants and the risk of cognitive decline in elderly women","volume":"23","author":"Ryan","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.arr.2015.08.001_bib0520","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jalz.2012.12.008","article-title":"Estrogen receptor polymorphisms and incident dementia: the prospective 3C study","volume":"10","author":"Ryan","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2015.08.001_bib0525","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1212\/WNL.0b013e3181c34b0c","article-title":"Characteristics of hormone therapy, cognitive function, and dementia: the prospective 3C Study","volume":"73","author":"Ryan","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2015.08.001_bib0530","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0006-8993(01)02610-5","article-title":"Hippocampal estrogen beta-receptor immunoreactivity is increased in Alzheimer\u2019s disease","volume":"908","author":"Savaskan","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2015.08.001_bib0535","first-page":"1","article-title":"Sex differences in Alzheimer\u2019s disease","volume":"22","author":"Schmidt","year":"2008","journal-title":"Neuropsychiatric"},{"key":"10.1016\/j.arr.2015.08.001_bib0540","unstructured":"Schnabel, J., July 8, 2013. Why do all the large Alzheimer\u2019s drug trials fail? http:\/\/www.dana.org\/News\/Why_Do_All_the_Large_Alzheimer_s_Drug_Trials_Fail_\/."},{"key":"10.1016\/j.arr.2015.08.001_bib0545","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2011.12.057","article-title":"Role of mitochondrial homeostasis and dynamics in Alzheimer\u2019s disease","volume":"51","author":"Selfridge","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.arr.2015.08.001_bib0550","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1126\/science.1177221","article-title":"Ribosomal protein S6 kinase 1 signaling regulates mammalian life span","volume":"326","author":"Selman","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.arr.2015.08.001_bib0555","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","article-title":"Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women\u2019s Health Initiative Memory Study","volume":"291","author":"Shumaker","year":"2004","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.arr.2015.08.001_bib0560","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women\u2019s Health Initiative Memory Study: a randomized controlled trial","volume":"289","author":"Shumaker","year":"2003","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.arr.2015.08.001_bib0565","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.brainresrev.2007.04.007","article-title":"Mitochondrial mechanisms of estrogen neuroprotection","volume":"57","author":"Simpkins","year":"2008","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.arr.2015.08.001_bib0570","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00018-004-4382-2","article-title":"Estrogens progestins, menopause and neurodegeneration: basic and clinical studies","volume":"62","author":"Simpkins","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.arr.2015.08.001_bib0575","doi-asserted-by":"crossref","first-page":"11110","DOI":"10.1073\/pnas.92.24.11110","article-title":"Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor","volume":"92","author":"Sohrabji","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.arr.2015.08.001_bib0580","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.2741\/3088","article-title":"Apolipoprotein E may be a critical factor in hormone therapy neuroprotection","volume":"13","author":"Struble","year":"2008","journal-title":"Front. Biosci."},{"key":"10.1016\/j.arr.2015.08.001_bib0585","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0014-4886(03)00215-2","article-title":"Regionally specific modulation of brain apolipoprotein E in the mouse during the estrous cycle and by exogenous 17beta estradiol","volume":"183","author":"Struble","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.arr.2015.08.001_bib0590","article-title":"The Alzheimer\u2019s disease mitochondrial cascade hypothesis:progress and perspectives","author":"Swerdlow","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.arr.2015.08.001_bib0595","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.brainresrev.2008.07.007","article-title":"New insights into brain BDNF function in normal aging and Alzheimer disease","volume":"59","author":"Tapia-Arancibia","year":"2008","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.arr.2015.08.001_bib0600","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1677\/jme.0.0240145","article-title":"Immunolocalisation of oestrogen receptor beta in human tissues","volume":"24","author":"Taylor","year":"2000","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.arr.2015.08.001_bib0605","first-page":"208","article-title":"Alzheimer\u2019s disease facts and figures","volume":"9","author":"Thies","year":"2013","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.arr.2015.08.001_bib0610","first-page":"420","article-title":"Estrogen receptor beta treats Alzheimer\u2019s disease","volume":"8","author":"Tian","year":"2013","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.arr.2015.08.001_bib0615","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1073\/pnas.89.10.4668","article-title":"Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain","volume":"89","author":"Toran-Allerand","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2015.08.001_bib0620","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s11682-013-9272-x","article-title":"Apolipoprotein E, gender, and Alzheimer\u2019s disease: an overlooked, but potent and promising interaction","volume":"8","author":"Ungar","year":"2014","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.arr.2015.08.001_bib0625","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/JGP.0b013e3181beaaf4","article-title":"Effects of hormone therapy on depressive symptoms and cognitive functions in women with Alzheimer disease: a 12 month randomized, double-blind, placebo-controlled study of low-dose estradiol and norethisterone","volume":"18","author":"Valen-Sendstad","year":"2010","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.arr.2015.08.001_bib0630","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.pbb.2006.07.003","article-title":"Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats","volume":"86","author":"Walf","year":"2007","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.arr.2015.08.001_bib0635","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1037\/a0012749","article-title":"Estradiol or diarylpropionitrile decrease anxiety-like behavior of wildtype, but not estrogen receptor beta knockout, mice","volume":"122","author":"Walf","year":"2008","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.arr.2015.08.001_bib0640","doi-asserted-by":"crossref","first-page":"16983","DOI":"10.1073\/pnas.0608128103","article-title":"Activation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo","volume":"103","author":"Wang","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2015.08.001_bib0645","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1073\/pnas.041617498","article-title":"Morphological abnormalities in the brains of estrogen receptor beta knockout mice","volume":"98","author":"Wang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2015.08.001_bib0650","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1073\/pnas.242735799","article-title":"Estrogen receptor (ER) beta knockout mice reveal a role for ERbeta in migration of cortical neurons in the developing brain","volume":"100","author":"Wang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2015.08.001_bib0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000334607","article-title":"Prevalence of apolipoprotein E4 genotype and homozygotes (APOE e4\/4) among patients diagnosed with Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"38","author":"Ward","year":"2012","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.arr.2015.08.001_bib0660","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.brainres.2010.09.069","article-title":"Estrogen and aging affect the synaptic distribution of estrogen receptor beta-immunoreactivity in the CA1 region of female rat hippocampus","volume":"1379","author":"Waters","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2015.08.001_bib0665","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0014-5793(03)00436-8","article-title":"Update on estrogen signaling","volume":"546","author":"Weihua","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.arr.2015.08.001_bib0670","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0047-6374(01)00406-7","article-title":"Age differentially influences estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) gene expression in specific regions of the rat brain","volume":"123","author":"Wilson","year":"2002","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.arr.2015.08.001_bib0675","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/archneur.1997.00550210044011","article-title":"Apolipoprotein E phenotype and cognitive decline in a prospective study of elderly community women","volume":"54","author":"Yaffe","year":"1997","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.arr.2015.08.001_bib0680","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1212\/WNL.54.10.1949","article-title":"Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction","volume":"54","author":"Yaffe","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2015.08.001_bib0685","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.neurobiolaging.2007.08.003","article-title":"Estrogen receptor genotype and risk of cognitive impairment in elders: findings from the Health ABC Study","volume":"30","author":"Yaffe","year":"2009","journal-title":"Neurobiol. Aging."},{"key":"10.1016\/j.arr.2015.08.001_bib0690","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1365-2826.2011.02231.x","article-title":"Changes in oestrogen receptor-beta mRNA expression in male rat brain with age","volume":"24","author":"Yamaguchi","year":"2012","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.arr.2015.08.001_bib0695","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1073\/pnas.0306948101","article-title":"Mitochondrial localization of estrogen receptor beta","volume":"101","author":"Yang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2015.08.001_bib0700","doi-asserted-by":"crossref","first-page":"14670","DOI":"10.1073\/pnas.0903563106","article-title":"Mitochondrial bioenergetic deficit precedes Alzheimer\u2019s pathology in female mouse model of Alzheimer\u2019s disease","volume":"106","author":"Yao","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.arr.2015.08.001_bib0705","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/dneu.20765","article-title":"Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease","volume":"70","author":"Yoshii","year":"2010","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.arr.2015.08.001_bib0710","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5858\/2010-0448-RAR.1","article-title":"Estrogen receptor beta","volume":"135","author":"Younes","year":"2011","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.arr.2015.08.001_bib0715","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1745-7254.2007.00618.x","article-title":"Effects of long-term, low-dose sex hormone replacement therapy on hippocampus and cognition of postmenopausal women of different apoE genotypes","volume":"28","author":"Yue","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.arr.2015.08.001_bib0720","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1212\/WNL.59.6.880","article-title":"Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study","volume":"59","author":"Zandi","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.arr.2015.08.001_bib0725","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1001\/jama.288.17.2123","article-title":"Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study","volume":"288","author":"Zandi","year":"2002","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.arr.2015.08.001_bib0730","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1021\/jm0490538","article-title":"Structure-based virtual screening for plant-based ERbeta-selective ligands as potential preventative therapy against age-related neurodegenerative diseases","volume":"48","author":"Zhao","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.arr.2015.08.001_bib0735","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/ddr.20049","article-title":"Estrogen receptor beta as a therapeutic target for promotion of neurogenesis and prevention of neurodegeneration","volume":"66","author":"Zhao","year":"2006","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.arr.2015.08.001_bib0740","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2202-7-24","article-title":"Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer\u2019s disease","volume":"7","author":"Zhao","year":"2006","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.arr.2015.08.001_bib0745","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.brainres.2007.06.092","article-title":"Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons","volume":"1172","author":"Zhao","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2015.08.001_bib0750","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1586\/14737175.7.11.1549","article-title":"WHI and WHIMS follow-up and human studies of soy isoflavones on cognition","volume":"7","author":"Zhao","year":"2007","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.arr.2015.08.001_bib0755","series-title":"Hormones, Cognition and Dementia: State of the Art and Emergent Therapeutic Strategies","first-page":"93","article-title":"In search of estrogen alternatives for the brain","author":"Zhao","year":"2009"},{"key":"10.1016\/j.arr.2015.08.001_bib0760","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1021\/jm070546x","article-title":"Design, synthesis, and estrogenic activity of a novel estrogen receptor modulator-a hybrid structure of 17beta-estradiol and vitamin E in hippocampal neurons","volume":"50","author":"Zhao","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.arr.2015.08.001_bib0765","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1210\/en.2008-0715","article-title":"A select combination of clinically relevant phytoestrogens enhances estrogen receptor beta-binding selectivity and neuroprotective activities in vitro and in vivo","volume":"150","author":"Zhao","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.arr.2015.08.001_bib0770","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3233\/JAD-122341","article-title":"Early intervention with an estrogen receptor beta-selective phytoestrogenic formulation prolongs survival, improves spatial recognition memory, and slows progression of amyloid pathology in a female mouse model of Alzheimer\u2019s disease","volume":"37","author":"Zhao","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2015.08.001_bib0775","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1097\/gme.0b013e3182175b66","article-title":"Estrogen receptor beta-selective phytoestrogenic formulation prevents physical and neurological changes in a preclinical model of human menopause","volume":"18","author":"Zhao","year":"2011","journal-title":"Menopause"},{"key":"10.1016\/j.arr.2015.08.001_bib0780","doi-asserted-by":"crossref","first-page":"e31267","DOI":"10.1371\/journal.pone.0031267","article-title":"Continuous versus cyclic progesterone exposure differentially regulates hippocampal gene expression and functional profiles","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.arr.2015.08.001_bib0785","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.brainresrev.2005.01.009","article-title":"Selective estrogen receptor modulators (SERMs) for the brain: current status and remaining challenges for developing NeuroSERMs","volume":"49","author":"Zhao","year":"2005","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.arr.2015.08.001_bib0790","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1124\/jpet.106.109504","article-title":"Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile","volume":"319","author":"Zhao","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.arr.2015.08.001_bib0795","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainres.2004.02.066","article-title":"Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons","volume":"1010","author":"Zhao","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.arr.2015.08.001_bib0800","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.neurobiolaging.2009.12.010","article-title":"17beta-Estradiol regulates insulin-degrading enzyme expression via an ERbeta\/PI3-K pathway in hippocampus: relevance to Alzheimer\u2019s prevention","volume":"32","author":"Zhao","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.arr.2015.08.001_bib0805","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000334522","article-title":"Estrogen receptor-Beta variants are associated with increased risk of Alzheimer\u2019s disease in women with down syndrome","volume":"32","author":"Zhao","year":"2011","journal-title":"Dement. Geriatr. Cogn. Disord."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163715300143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163715300143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T17:57:23Z","timestamp":1718042243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163715300143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":161,"alternative-id":["S1568163715300143"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2015.08.001","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estrogen receptor \u03b2 in Alzheimer\u2019s disease: From mechanisms to therapeutics","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2015.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}